President Donald Trump has signed an executive order (EO) to ease restrictions on the use of psychedelic drugs to treat serious mental illness, including post-traumatic stress disorder and brain trauma.
The EO directs the commissioner of the US Food and Drug Administration (FDA) to provide Commissioner’s National Priority Vouchers